New hope for Alzheimer’s patients? Cancer drug shows ‘high potential’
A type of drug being developed to combat cancer could be repurposed to treat Alzheimer’s disease in its early stages, new research finds. Blocking an enzyme called indoleamine-2,3-dioxygenase 1 (IDO1) can rescue memory and brain function in models that mimic Alzheimer’s, Penn State researchers say. IDO1 inhibitors have already shown promise in the fight against … Read more